Angelman Syndrome – Gene Therapy | Tuberous sclerosis – Information for GPs

   Rated 5 / 5 stars

Save

CPD for this activity

Educational Activities (EA)

0.5 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0.5 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
0.5 mins

Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0.5 mins

Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.

MO
0 mins

Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.

Listen to the episode

Description

Part 1: Angelman Syndrome – Gene Therapy

  • How gene therapy works
  • The conditions for which gene therapy is currently approved
  • The future direction of gene therapy and in particular its potential for treating conditions such as Angelman Syndrome

 

Host: Dr Terri Foran, Medical Educator

Expert: Prof David Segal, Biochemistry & Molecular Medicine

Recommended resources:

 

Part 2: Tuberous sclerosis – Information for GPs

  • The clinical manifestations of Tuberous Sclerosis Complex (TSC)
  • The genetics of TSC
  • The importance of early diagnosis of TSC
  • New therapies for the management of TSC
  • Recommended clinical surveillance for those with a diagnosis of TSC

 

Host: Dr Terri Foran, Medical Educator

Expert: Dr Clara Chung, Clinical Geneticist

Recommended resources:

Last Updated: 12 Jul, 2024

Rate this podcast
Help your colleagues find podcasts they'll enjoy by rating this podcast out of five stars.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Rod Baber

Prof Rod Baber

Menopause and MHT: Maximising Benefits & Minimising Risks

Dr Fiona Chan

Dr Fiona Chan

Multiple Sclerosis vs Antibody Disease – What GPs Need to Know

Prof Andrew Sindone & Dr Ted Wu

Prof Andrew Sindone & Dr Ted Wu

Using SGLT2 to Reduce Cardiovascular Death in T2D – Important Updates for GPs

Dr Shannon Thomas

Dr Shannon Thomas

Peripheral Arterial Disease

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof David J. Segal

expert

Prof David J. Segal

Biochemistry and Molecular Medicine, Pharmacology, Genome Center, MIND Institute; Co-Chair, Integrative Genetics and Genomics graduate group; Field Chief Editor, Frontiers in Genome Editing

Dr Clara Chung

expert

Dr Clara Chung

Clinical Geneticist; Sydney Children’s Hospital and Liverpool Hospital; Conjoint Lecturer, UNSW, Sydney

Recent articles

Find your area of interest

Share this

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.

Menopause and MHT

Multiple sclerosis vs antibody disease

Using SGLT2 to reduce cardiovascular death in T2D

Peripheral arterial disease